Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 50008192
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374633(US10246462, Example 14 | 6-((3R,4S)-4-(Azepan-1-yl...)
Affinity DataIC50: 23nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374652(US10246462, Example 33 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 27nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516634(CHEMBL4473604)
Affinity DataIC50: 32nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374650(US10246462, Example 31 | ((S)-1-((3R,4S)-1-(1-((R)...)
Affinity DataIC50: 32nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516626(CHEMBL4475665)
Affinity DataIC50: 34nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516632(CHEMBL4443688)
Affinity DataIC50: 36nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516623(CHEMBL4575089)
Affinity DataIC50: 37nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516625(CHEMBL4459231)
Affinity DataIC50: 40nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516635(CHEMBL4518040)
Affinity DataIC50: 41nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516633(CHEMBL4465359)
Affinity DataIC50: 42nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516626(CHEMBL4475665)
Affinity DataIC50: 44nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374639(US10246462, Example 20 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 47nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516627(CHEMBL4522437)
Affinity DataIC50: 54nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516621(CHEMBL4483537)
Affinity DataIC50: 54nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374652(US10246462, Example 33 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 58nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374632(US10246462, Example 13 | 6-((3R,4S)-4-(Azetidin-1-...)
Affinity DataIC50: 58nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516629(CHEMBL4566304)
Affinity DataIC50: 69nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516625(CHEMBL4459231)
Affinity DataIC50: 70nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516631(CHEMBL4448901)
Affinity DataIC50: 104nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516628(CHEMBL4522547)
Affinity DataIC50: 126nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374650(US10246462, Example 31 | ((S)-1-((3R,4S)-1-(1-((R)...)
Affinity DataIC50: 151nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Mouse)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516625(CHEMBL4459231)
Affinity DataIC50: 165nMAssay Description:Antagonist activity at CCR4 in anti-CD3/CD28 stimulated mouse Treg cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516630(CHEMBL4583503)
Affinity DataIC50: 170nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374641(US10246462, Example 22 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 172nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516632(CHEMBL4443688)
Affinity DataIC50: 179nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374633(US10246462, Example 14 | 6-((3R,4S)-4-(Azepan-1-yl...)
Affinity DataIC50: 195nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374632(US10246462, Example 13 | 6-((3R,4S)-4-(Azetidin-1-...)
Affinity DataIC50: 218nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374623(US10246462, Example 4 | 1-(1-(2,4-Dichlorophenyl)e...)
Affinity DataIC50: 228nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516624(CHEMBL4455432)
Affinity DataIC50: 229nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374627(US10246462, Example 8 | 1-(1-(2,4-Dichlorophenyl)e...)
Affinity DataIC50: 238nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516622(CHEMBL4566241)
Affinity DataIC50: 251nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516634(CHEMBL4473604)
Affinity DataIC50: 259nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516638(CHEMBL4437594)
Affinity DataIC50: 275nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Mouse)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516626(CHEMBL4475665)
Affinity DataIC50: 325nMAssay Description:Antagonist activity at CCR4 in anti-CD3/CD28 stimulated mouse Treg cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516623(CHEMBL4575089)
Affinity DataIC50: 355nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516633(CHEMBL4465359)
Affinity DataIC50: 361nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374639(US10246462, Example 20 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 381nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516636(CHEMBL4555534)
Affinity DataIC50: 384nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516624(CHEMBL4455432)
Affinity DataIC50: 638nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374653(US10246462, Example 34 | ((3R,4S)-1-(1-((R)-1-(2,4...)
Affinity DataIC50: 670nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516640(CHEMBL4537681)
Affinity DataIC50: 803nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374629(US10246462, Example 10 | 1-(1-(2,4-Dichlorophenyl)...)
Affinity DataIC50: 837nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516635(CHEMBL4518040)
Affinity DataIC50: 865nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516636(CHEMBL4555534)
Affinity DataIC50: 1.20E+3nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516621(CHEMBL4483537)
Affinity DataIC50: 1.38E+3nMAssay Description:Antagonist activity at CCR4 in human CCRF-CEM cells assessed as inhibition of CCL22-mediated chemotaxis in presence of 100% human serum pre-incubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516637(CHEMBL4446924)
Affinity DataIC50: 2.58E+3nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516639(CHEMBL4459504)
Affinity DataIC50: 5.00E+3nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374652(US10246462, Example 33 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM374652(US10246462, Example 33 | 1-((R)-1-(2,4-Dichlorophe...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50516625(CHEMBL4459231)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: